Federal Register / Vol. 76, No. 66 / Wednesday, April 6, 2011 / Notices 19189 

Panel Date(s) Location 

Immunology .............................................................................................. June 9, 2011 .................................. L’Enfant Plaza Hotel. 

Infectious Diseases-A ............................................................................... June 9, 2011 .................................. L’Enfant Plaza Hotel. 

Cardiovascular Studies ............................................................................. June 10, 2011 ................................ Crowne Plaza DC/Silver Spring. 

Neurobiology-D ......................................................................................... June 10, 2011 ................................ Crowne Plaza DC/Silver Spring. 

Clinical Research Program ....................................................................... June 13, 2011 ................................ VA Central Office.* 

Gastroenterology ...................................................................................... June 13, 2011 ................................ L’Enfant Plaza Hotel. 

The addresses of the hotels and VA Central Office are: 

Plaza Washington DC/Silver Spring, 8777 Georgia Avenue, Silver Spring, MD. 

Hamilton Crowne Plaza, 1001–14th Street, NW., Washington, DC. 

L’Enfant Plaza Hotel, 480 L’Enfant Plaza, SW., Washington, DC. 

* VA Central Office, 131 M Street, NE., Washington, DC. 

* Teleconference. 

The purpose of the Merit Review 

Board is to provide advice on the 

scientific quality, budget, safety and 

mission relevance of investigatorinitiated research proposals submitted 

for VA merit review consideration. 

Proposals submitted for review by the 

Board involve a wide range of medical 

specialties within the general areas of 

biomedical, behavioral and clinical 

science research. 

The panel meetings will be open to 

the public for approximately one hour at 

the start of each meeting to discuss the 

general status of the program. The 

remaining portion of each panel meeting 

will be closed to the public for the 

review, discussion, and evaluation of 

initial and renewal research proposals. 

The closed portion of each meeting 

involves discussion, examination, 

reference to staff and consultant 

critiques of research proposals. During 

this portion of each meeting, discussion 

and recommendations will deal with 

qualifications of personnel conducting 

the studies, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy, as well as 

research information, the premature 

disclosure of which could significantly 

frustrate implementation of proposed 

agency action regarding such research 

proposals. 

As provided by subsection 10(d) of 

Public Law 92–463, as amended, closing 

portions of these panel meetings is in 

accordance with 5 U.S.C., 552b(c)(6) 

and (9)(B). Those who plan to attend or 

would like to obtain a copy of minutes 

of the panel meetings and rosters of the 

members of the panels should contact 

LeRoy G. Frey, PhD, Chief, Program 

Review (121F), Department of Veterans 

Affairs, 810 Vermont Avenue, NW., 

Washington, DC 20420 at (202) 443– 

5674. 

Dated: March 31, 2011. 

By Direction of the Secretary. 

William F. Russo, 

Director of Regulations Management, Office 

of General Counsel. 

[FR Doc. 2011–8114 Filed 4–5–11; 8:45 am] 

BILLING CODE 8320–01–P 

DEPARTMENT OF VETERANS 

AFFAIRS 

Clinical Science Research and 

Development Service Cooperative 

Studies Scientific Evaluation 

Committee; Notice of Meeting 

The Department of Veterans Affairs 

(VA) gives notice under Public Law 92– 

463 (Federal Advisory Committee Act) 

that a meeting of the Clinical Science 

Research and Development Service 

Cooperative Studies Scientific 

Evaluation Committee will be held on 

April 25, 2011, at The Ritz-Carlton 

Hotel, 1150 22nd Street, NW., 

Washington, DC. The meeting is 

scheduled to begin at 9 a.m. and end at 

3 p.m. 

The Committee advises the Chief 

Research and Development Officer 

through the Director of the Clinical 

Science Research and Development 

Service on the relevance and feasibility 

of proposed projects and the scientific 

validity and propriety of technical 

details, including protection of human 

subjects. 

The session will be open to the public 

for approximately 30 minutes at the 

start of the meeting for the discussion of 

administrative matters and the general 

status of the program. The remaining 

portion of the meeting will be closed to 

the public for the Committee’s review, 

discussion and evaluation of research 

and development applications. 

During the closed portion of the 

meeting, discussions and 

recommendations will deal with 

qualifications of personnel conducting 

the studies, staff and consultant 

critiques of research proposals and 

similar documents and the medical 

records of patients who are study 

subjects, the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. As 

provided by section 10(d) of Public Law 

92–463, as amended, closing portions of 

this meeting is in accordance with 5 

U.S.C. 552b(c)(6) and (c)(9)(B). 

Those who plan to attend should 

contact Dr. Grant Huang, Deputy 

Director, Cooperative Studies Program 

(125), Department of Veterans Affairs, 

810 Vermont Avenue, NW., 

Washington, DC 20420, or e-mail at 

grant.huang@va.gov or phone at (202) 

443–5600. 

Dated: March 31, 2011. 

By Direction of the Secretary. 

William F. Russo, 

Director of Regulations Management, Office 

of General Counsel. 

[FR Doc. 2011–8115 Filed 4–5–11; 8:45 am] 

BILLING CODE P 

mstockstill on DSKH9S0YB1PROD with NOTICES